Cargando…

IgG and IgM antibody formation to spike and nucleocapsid proteins in COVID-19 characterized by multiplex immunoblot assays

BACKGROUND: Rapid and simple serological assays for characterizing antibody responses are important in the current COVID-19 pandemic caused by SARS-CoV-2. Multiplex immunoblot (IB) assays termed COVID-19 IB assays were developed for detecting IgG and IgM antibodies to SARS-CoV-2 virus proteins in CO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shah, Jyotsna, Liu, Song, Potula, Hari-Hara, Bhargava, Prerna, Cruz, Iris, Force, Denise, Bazerbashi, Ammar, Ramasamy, Ranjan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025059/ https://www.ncbi.nlm.nih.gov/pubmed/33827460 http://dx.doi.org/10.1186/s12879-021-06031-9

Ejemplares similares

Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies
por: Takahashi, Maika, et al.
Publicado: (2022)

Multiplex Microsphere Immunoassays for the Detection of IgM and IgG to Arboviral Diseases
por: Basile, Alison J., et al.
Publicado: (2013)

2D immunoblots show differential response of mouse IgG and IgM antibodies to antigens of mammary carcinoma 4 T1 cells
por: Díaz-Zaragoza, Mariana, et al.
Publicado: (2014)

Performance of the Roche/Snibe electrochemiluminescent anti-SARS-COV-2 spike assays compared to the Roche/Abbott IgG nucleocapsid and Abbott IgM spike assays
por: Lau, C.S., et al.
Publicado: (2021)

Simultaneous Measurement of IgM and IgG Antibodies to SARS-CoV-2 Spike, RBD, and Nucleocapsid Multiplexed in a Single Assay on the xMAP INTELLIFLEX DR-SE Flow Analyzer
por: Cameron, Andrew, et al.
Publicado: (2022)

Diagnosis of antigenic markers of acute toxoplasmosis by IgG avidity immunoblotting
por: Ali-Heydari, Siamak, et al.
Publicado: (2013)

IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection
por: Choudhary, Hari Ram, et al.
Publicado: (2021)

Helper T cells reacting to idiotype on IgG but not IgM
Publicado: (1985)

Development of a Nucleocapsid Protein-Based ELISA for Detection of Human IgM and IgG Antibodies to SARS-CoV-2
por: Liu, Pan-pan, et al.
Publicado: (2021)

A New IgG Immunoblot Kit for Diagnosis of Toxoplasmosis in Pregnant Women
por: Khammari, Imen, et al.
Publicado: (2014)

Serum IgA, IgM, and IgG responses in COVID-19
por: Ma, Huan, et al.
Publicado: (2020)

Borrelia multiplex: a bead-based multiplex assay for the simultaneous detection of Borrelia specific IgG/IgM class antibodies
por: Häring, Julia, et al.
Publicado: (2022)

Serologic Tests of IgG and IgM Antibodies and IgG Avidity for Diagnosis of Ocular Toxoplasmosis
por: Rahimi-Esboei, Bahman, et al.
Publicado: (2018)

Association of dengue infection with anti-alpha-gal antibodies, IgM, IgG, IgG1, and IgG2
por: Olajiga, Olayinka M., et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India
por: Lone, Kouser Sideeq, et al.
Publicado: (2022)

A Highly Sensitive and Specific SARS-CoV-2 Spike- and Nucleoprotein-Based Fluorescent Multiplex Immunoassay (FMIA) to Measure IgG, IgA, and IgM Class Antibodies
por: Solastie, Anna, et al.
Publicado: (2021)

Reference ranges for serum immunoglobulin (IgG, IgA, and IgM) and IgG subclass levels in healthy children
por: BAYRAM, Rumeysa Olcay, et al.
Publicado: (2019)

Detection of serum IgM and IgG for COVID-19 diagnosis
por: Zhong, Ling, et al.
Publicado: (2020)

The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19
por: Qin, Xuzhen, et al.
Publicado: (2021)

Rheumatoid factor IgM autoantibodies control IgG homeostasis
por: Nicolò, Antonella, et al.
Publicado: (2022)

Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months
por: Serwanga, Jennifer, et al.
Publicado: (2023)

Staphylococcus pseudintermedius Sbi paralogs inhibit complement and bind IgM, IgG Fc and Fab
por: Sewid, Alaa H., et al.
Publicado: (2019)

Determination of IgG1 and IgG3 SARS-CoV-2 Spike Protein and Nucleocapsid Binding—Who Is Binding Who and Why?
por: Iles, Jason K., et al.
Publicado: (2022)

Development of a Multiplex Glycan Microarray Assay and Comparative Analysis of Human Serum Anti-Glycan IgA, IgG, and IgM Repertoires
por: Durbin, Sarah V., et al.
Publicado: (2018)

IgG, IgM and IgA antibodies against the novel polyprotein in active tuberculosis
por: Feng, Xiaoyan, et al.
Publicado: (2014)

Competition between Serum IgG, IgM, and IgA Anti-Glycan Antibodies
por: Muthana, Saddam M., et al.
Publicado: (2015)

MONOCLONAL PRODUCTION OF BOTH IgM AND IgG1 ANTIHAPTEN ANTIBODY
por: Press, Joan L., et al.
Publicado: (1973)

IgG and IgM autoantibody differences in discoid and systemic lupus patients
por: Chong, Benjamin F., et al.
Publicado: (2012)

Simultaneous Quantification of Anticardiolipin IgG and IgM by Time Resolved Fluoroimmunoassay
por: Hu, Zhigang, et al.
Publicado: (2016)

Comparison of in-house IgM and IgG ELISAs for the serodiagnosis of melioidosis in Malaysia
por: Hii, Shirley Yi Fen, et al.
Publicado: (2017)

Patterns of IgG and IgM antibody response in COVID-19 patients
por: Liu, Xuemei, et al.
Publicado: (2020)

Detection of IgM and IgG antibodies in patients with coronavirus disease 2019
por: Hou, Hongyan, et al.
Publicado: (2020)

Seroprevalence of CMV IgG and IgM in Korean women of childbearing age
por: Choi, Rihwa, et al.
Publicado: (2021)

SARS-COV-2 IgG and IgM Antibodies in Cancer Patients
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Erratum: Rheumatoid factor IgM autoantibodies control IgG homeostasis
Publicado: (2022)

IgM triplet in neonatal diagnosis by immunoblotting and its potential use as a diagnostic marker for congenital toxoplasmosis
por: Peyclit, Lucie, et al.
Publicado: (2023)

Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countries
por: Begeman, Ian J., et al.
Publicado: (2017)

In Men at Risk of HIV Infection, IgM, IgG1, IgG3 and IgA Reach the Human Foreskin Epidermis
por: Lemos, Maria P., et al.
Publicado: (2015)

Application of recombinant severe fever with thrombocytopenia syndrome virus nucleocapsid protein for the detection of SFTSV-specific human IgG and IgM antibodies by indirect ELISA
por: Yu, Fuxun, et al.
Publicado: (2015)

Multiplex Antibody Analysis of IgM, IgA and IgG to SARS-CoV-2 in Saliva and Serum From Infected Children and Their Close Contacts
por: Dobaño, Carlota, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tirjp0sl1f882m81tbb04736r6